Research chemical
CAS Number: 1088-11-5
Product details
For laboratory research and professional procurement workflows.
PubChem CID
2997
Exact Mass
270.055991
InChIKey
AKPLHCDWDRPJGD-UHFFFAOYSA-N
IUPAC Name
7-chloro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one
SMILES String
OC1=Nc2ccc(Cl)cc2C(c2ccccc2)=NC1
No physical property values available.
Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.
Catalog navigation
Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.
Nordiazepam is identified by CAS 1088-11-5, with molecular formula C15H11ClN2O, molecular weight 270.71, InChIKey AKPLHCDWDRPJGD-UHFFFAOYSA-N.
ChEMBL contains qualifying experimental assay evidence associated with Cannabinoid receptor 1, Gamma-aminobutyric acid receptor subunit alpha-1, 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B. These records do not establish therapeutic efficacy or clinical use.
Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.
Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.
Availability, pack size, lead time, and pricing are confirmed through RFQ.
Heavy atom count
19
H-bond acceptors
3
H-bond donors
1
Rotatable bonds
1
Ring count
3
Aromatic rings
2
Topological polar surface area
44.95 Ų
Computed LogP
3.78
Fragment-like structure rule
Yes
Lead-like structure rule
Yes
Drug-like structure rule
Yes
Structure family
n heterocycle ligand
Precious metal motif
No
Transition metal motif
No
Phosphine ligand motif
No
N-heterocycle motif
Yes
Boronic acid motif
No
Computed structure descriptors generated from molecular structure. These are not experimental physical property values, supplier specifications, SDS data, or bioactivity claims.
Structural features
Nordiazepam (CAS 1088-11-5) is maintained as a commercial cas reference with formula C15H11ClN2O, molecular weight 270. 71 g/mol, PubChem CID 2997.
Sourcing context
Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.
Research use context
Use this page for CAS identity lookup, internal catalog search, and commercial discovery workflows; structure-derived tags include nitrogen-containing heterocycle, fragment-like structure profile, lead-like structure profile, drug-like rule profile.
Documentation needs
Review supplier documentation before handling; for research use only.
ChEMBL reports experimental activity evidence for: Cannabinoid receptor 1 (Homo sapiens) — 4 assays; Gamma-aminobutyric acid receptor subunit alpha-1 (Rattus norvegicus) — 2 assays; 5-hydroxytryptamine receptor 1A (Homo sapiens) — 3 assays; 5-hydroxytryptamine receptor 2A (Homo sapiens) — 3 assays; 5-hydroxytryptamine receptor 2B (Homo sapiens) — 3 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.
Cannabinoid receptor 1
Homo sapiens · SINGLE PROTEIN · 4 qualifying assays · 1 documents · best pChEMBL 9.22
Experimental evidence source: ChEMBL
Gamma-aminobutyric acid receptor subunit alpha-1
Rattus norvegicus · SINGLE PROTEIN · 2 qualifying assays · 1 documents · best pChEMBL 7.31
Experimental evidence source: ChEMBL
5-hydroxytryptamine receptor 1A
Homo sapiens · SINGLE PROTEIN · 3 qualifying assays · 1 documents
Experimental evidence source: ChEMBL
5-hydroxytryptamine receptor 2A
Homo sapiens · SINGLE PROTEIN · 3 qualifying assays · 1 documents
Experimental evidence source: ChEMBL
5-hydroxytryptamine receptor 2B
Homo sapiens · SINGLE PROTEIN · 3 qualifying assays · 1 documents
Experimental evidence source: ChEMBL
Safety and handling reference content is available through documentation requests.
For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.
Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.